NCT05991219View on ClinicalTrials.gov

Screening and Secondary Prevention Rheumatic Heart Disease Study

RecruitingOBSERVATIONAL

Enrollment

5,000

Participants

Timeline

Start Date

September 26, 2022

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions

Rheumatic Heart Disease

Trial Locations (1)

75510

RECRUITING

National Institute of Cardiovascular Diseases (NICVD), Karachi

All Listed Sponsors

lead

National Institute of Cardiovascular Diseases, Pakistan

OTHER